Skip to content
Screener

ICU Medical ICUI Income (Loss) from Continuing Operations before Equity Method Investments

Income (Loss) from Continuing Operations before Equity Method Investments at other companies

Mid-America Apartment Communities logo
Mid-America Apartment CommunitiesMAA
$126.35M-32.1%
United States Antimony logo
United States AntimonyUAMY
$166.8K-8.1%
United States Antimony logo
United States AntimonyUAMY
$166.8K-8.1%
Deere & Company logo
Deere & CompanyDE
$1.78B-1.3%
Linde logo
LindeLIN
$1.86B+11.4%
Lesaka Technologies, Inc. logo
Lesaka Technologies, Inc.LSAK
$381K+102%

Other financials

Income statement

See full
Revenue$551.7M+0.5%
Gross profit$235.1M+13.0%
Operating income$39.1M+270%
Net income$19.1M-46.0%
EPS (diluted)$0.76-46.9%

Balance sheet

See full
Cash & equivalents$298.3M-0.6%
Total debt$1.3B-7.1%
Total equity$2.2B+1.7%
Total assets$4.0B-3.3%

Cash flow

See full
Operating cash flow$80.2M+615%
CapEx$18.5M-6.0%
Free cash flow$61.6M

Valuation

See full
Market cap$4.61B+72.9%
Enterprise value$5.62B+48.9%
P/E56.8×
P/S2.1×+1.0×

Profitability

See full
Gross margin39.1%+3.3pp
Operating margin3.3%+0.4pp
Net margin-0.3%-0.2pp
FCF margin7.1%+4.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.1×
Current ratio2.4×0.0×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept icui:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments.

The source filing: ICU Medical’s 10-K, filed February 19, 2026.

Filed
Feb 19, 2026, 4:40 PM EST
Fiscal year
FY2025
Accession
0000883984-26-000008
Line itemYear ended December 31, 2025Year ended December 31, 2024Year ended December 31, 2023
GAIN ON SALE OF BUSINESS44,792
INCOME (LOSS) BEFORE INCOME TAXES AND EQUITY IN LOSSES OF UNCONSOLIDATED AFFILIATES4,358(66,012)(78,299)
(PROVISION) BENEFIT FOR INCOME TAXES(2,437)(51,676)48,644
NET INCOME (LOSS) FROM CONSOLIDATED COMPANIES$1,921$(117,688)$(29,655)
EQUITY IN LOSSES OF UNCONSOLIDATED AFFILIATES(1,189)
NET INCOME (LOSS)$732$(117,688)$(29,655)
NET INCOME (LOSS) PER SHARE
Basic$0.03$(4.83)$(1.23)

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is ICU Medical's income (loss) from continuing operations before equity method investments?
ICU Medical (ICUI) reported income (loss) from continuing operations before equity method investments of $480.25K in Q4 2025.
How has ICU Medical's income (loss) from continuing operations before equity method investments changed year-over-year?
ICU Medical's income (loss) from continuing operations before equity method investments increased by 101.6% year-over-year, from -$29.42M to $480.25K.
What is the long-term trend for ICU Medical's income (loss) from continuing operations before equity method investments?
Over 2 years (2023 to 2025), ICU Medical's income (loss) from continuing operations before equity method investments has grown at a -74.5% compound annual growth rate (CAGR), from -$29.66M to $1.92M.
What does income (loss) from continuing operations before equity method investments mean?
This metric measures the profitability of core business operations excluding the impact of equity method investments and non-operating items. It provides a clearer view of the underlying performance of the company's primary business segments before accounting for the results of unconsolidated affiliates. This figure is essential for evaluating the operational health and core earnings power of the enterprise.

Ask your AI about ICU Medical's income (loss) from continuing operations before equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude